Literature DB >> 16780546

Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation.

J M Gloor1, F G Cosio, D J Rea, H M Wadei, J L Winters, S B Moore, S R DeGoey, D J Lager, J P Grande, M D Stegall.   

Abstract

Recent protocols have allowed successful positive crossmatch (+XM) and ABO incompatible (ABOI) kidney transplantation, although their long-term outcome is not clear. To begin to assess this issue we compared protocol biopsies performed 12 months posttransplant in 37 +XM, 24 ABOI and 198 conventional allografts. Although the majority in all three groups had only minimal histologic changes, transplant glomerulopathy (TG) was significantly increased in +XM (22% vs. 13% ABOI vs. 8% conventional, p = 0.015), and correlated with prior humoral rejection (HR) by multivariate analysis (odds ratio 17.5, p < or = 0.0001). Patients with a prior history of HR also had a significant increase in interstitial fibrosis (No HR 54% vs. HR 86%, p = 0.045). In the absence of HR no difference in histologic changes was seen between groups, although all three groups had a demonstrable mild increase in interstitial fibrosis from biopsies performed at the time of transplant. Thus, although HR is associated with an increase in TG, in its absence allograft histology is similar in +XM, ABOI and conventional allografts 1 year posttransplant.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16780546     DOI: 10.1111/j.1600-6143.2006.01416.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  26 in total

Review 1.  The impact of donor-specific anti-HLA antibodies on late kidney allograft failure.

Authors:  Alexandre Loupy; Gary S Hill; Stanley C Jordan
Journal:  Nat Rev Nephrol       Date:  2012-04-17       Impact factor: 28.314

2.  Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation.

Authors:  Gary S Hill; Dominique Nochy; Patrick Bruneval; J P Duong van Huyen; Denis Glotz; Caroline Suberbielle; Julien Zuber; Dany Anglicheau; Jean-Philippe Empana; Christophe Legendre; Alexandre Loupy
Journal:  J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 10.121

Review 3.  Effector mechanisms of rejection.

Authors:  Aurélie Moreau; Emilie Varey; Ignacio Anegon; Maria-Cristina Cuturi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

4.  C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts.

Authors:  Mark Haas; Dorry L Segev; Lorraine C Racusen; Serena M Bagnasco; Jayme E Locke; Daniel S Warren; Christopher E Simpkins; Diane Lepley; Karen E King; Edward S Kraus; Robert A Montgomery
Journal:  J Am Soc Nephrol       Date:  2008-09-05       Impact factor: 10.121

5.  Perception versus reality?: Virtual crossmatch--how to overcome some of the technical and logistic limitations.

Authors:  A R Tambur; D S Ramon; D B Kaufman; J Friedewald; X Luo; B Ho; A Skaro; J Caicedo; D Ladner; T Baker; J Fryer; L Gallon; J Miller; M M Abecassis; J Leventhal
Journal:  Am J Transplant       Date:  2009-06-26       Impact factor: 8.086

Review 6.  Treatment options and strategies for antibody mediated rejection after renal transplantation.

Authors:  Matthew H Levine; Peter L Abt
Journal:  Semin Immunol       Date:  2011-09-21       Impact factor: 11.130

Review 7.  Identification and therapeutic management of highly sensitized patients undergoing renal transplantation.

Authors:  Lu Huber; Nils Lachmann; Michael Dürr; Mareen Matz; Lutz Liefeldt; Hans-H Neumayer; Constanze Schönemann; Klemens Budde
Journal:  Drugs       Date:  2012-07-09       Impact factor: 9.546

8.  Kidney Transplant With Low Levels of DSA or Low Positive B-Flow Crossmatch: An Underappreciated Option for Highly Sensitized Transplant Candidates.

Authors:  Carrie A Schinstock; Manish Gandhi; Wisit Cheungpasitporn; Donald Mitema; Mikel Prieto; Patrick Dean; Lynn Cornell; Fernando Cosio; Mark Stegall
Journal:  Transplantation       Date:  2017-10       Impact factor: 4.939

Review 9.  Strategies to overcome the ABO barrier in kidney transplantation.

Authors:  Georg A Böhmig; Andreas M Farkas; Farsad Eskandary; Thomas Wekerle
Journal:  Nat Rev Nephrol       Date:  2015-09-01       Impact factor: 28.314

10.  Addition of plasmapheresis decreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies.

Authors:  Enver Akalin; Rajani Dinavahi; Rex Friedlander; Scott Ames; Graciela de Boccardo; Vinita Sehgal; Bernd Schröppel; Madhu Bhaskaran; Susan Lerner; Marileno Fotino; Barbara Murphy; Jonathan S Bromberg
Journal:  Clin J Am Soc Nephrol       Date:  2008-03-12       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.